Journal of Clinical Endocrinology & Metabolism, Vol 78, 1090-1096, Copyright © 1994 by Endocrine Society

ARTICLES

Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide

U Renner, S Brockmeier, CJ Strasburger, M Lange, J Schopohl, OA Muller, K von Werder and GK Stalla
Max-Planck Institute of Psychiatry, Clinical Institute, Munich, Germany.

The synthetic hexapeptide GH-releasing peptide (GHRP; His-D-Trp-Ala-Trp- D-Phe-Lys-NH2) specifically stimulates GH secretion in humans in vivo and in animals in vitro and in vivo via a still unknown receptor and mechanism. To determine the effect of GHRP on human somatotroph cells in vitro, we stimulated cell cultures derived from 12 different human somatotroph adenomas with GHRP alone and in combination with GH- releasing hormone (GHRH), TRH, and the somatostatin analog octreotide. GH secretion of all 12 adenoma cultures could be stimulated with GHRP, whereas GHRH was active only in 6 adenoma cultures. In GHRH-responsive cell cultures, simultaneous application of GHRH and GHRP had an additive effect on GH secretion. TRH stimulated GH release in 4 of 7 adenoma cultures; in TRH-responsive cell cultures there was also an additive effect of GHRP and TRH on GH secretion. In 5 of 9 adenoma cultures investigated, octreotide inhibited basal GH secretion. In these cell cultures, GHRP-induced GH release was suppressed by octreotide. In 5 of 5 cases, the protein kinase-C inhibitor phloretin partly inhibited GHRP-stimulated GH release, but not basal GH secretion. In summary, GH secretion was stimulated by GHRP in all somatotroph adenomas investigated, indicating that its unknown receptor and signaling pathway are expressed more consistently in somatotroph adenoma cells than those for GHRH, TRH, and somatostatin. Our data give further evidence that GHRP-stimulated GH secretion is mediated by a receptor different from that for GHRH or TRH, respectively, and that protein kinase-C is involved in the signal transduction pathway. Because human somatotroph adenoma cell cultures respond differently to various neuropeptides (GHRH, TRH, somatostatin, and others), they provide a model for further investigation of the mechanism of action of GHRP-induced GH secretion.

This article has been cited by other articles:

				R. D. Kineman and R. M. Luque Evidence that Ghrelin Is as Potent as Growth Hormone (GH)-Releasing Hormone (GHRH) in Releasing GH from Primary Pituitary Cell Cultures of a Nonhuman Primate (Papio anubis), Acting through Intracellular Signaling Pathways Distinct from GHRH Endocrinology, September 1, 2007; 148(9): 4440 - 4449. [Abstract] [Full Text] [PDF]

				E. V. Dimaraki, W. F. Chandler, M. B. Brown, C. A. Jaffe, S. Y. Kim, R. Taussig, V. Padmanabhan, and A. L. Barkan The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2185 - 2190. [Abstract] [Full Text] [PDF]

				U. Pagotto, G. Marsicano, F. Fezza, M. Theodoropoulou, Y. Grubler, J. Stalla, T. Arzberger, A. Milone, M. Losa, V. Di Marzo, et al. Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence for a Direct Role of Cannabinoids on Hormone Modulation at the Human Pituitary Level J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2687 - 2696. [Abstract] [Full Text] [PDF]

				A.-C. A. R. Pinto, M. R. D. Silva, M. R. Martins, E. Brunner, and A.-M. J. Lengyel Effects of Short-Term Glucocorticoid Deprivation on Growth Hormone (GH) Response to GH-Releasing Peptide-6: Studies in Normal Men and in Patients with Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1540 - 1544. [Abstract] [Full Text]

				P. Jaquet, A. Saveanu, G. Gunz, F. Fina, A. J. Zamora, M. Grino, M. D. Culler, J. P. Moreau, A. Enjalbert, and L'H. Ouafik Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral Phenotypes J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 781 - 792. [Abstract] [Full Text]

				P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320. [Abstract] [Full Text]

				K. Hanew, A. Utsumi, A. Tanaka, H. Ikeda, and Y. Yokogoshi Secretory Mechanisms of Growth Hormone (GH)-Releasing Peptide-, GH-Releasing Hormone-, and Thyrotropin-Releasing Hormone-Induced GH Release in Patients with Acromegaly J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3578 - 3583. [Abstract] [Full Text]

				M. Korbonits, R. A. Jacobs, S. J. B. Aylwin, J. M. Burrin, P. L. M. Dahia, J. P. Monson, J. Honegger, R. Fahlbush, P. J. Trainer, S. L. Chew, et al. Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3624 - 3630. [Abstract] [Full Text]

				S. Nielsen, S. Mellemkjær, L. M. Rasmussen, T. Ledet, J. Astrup, J. Weeke, and J. O. L. Jørgensen Gene Transcription of Receptors for Growth Hormone-Releasing Peptide and Somatostatin in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2997 - 3000. [Abstract] [Full Text]

				J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434. [Abstract] [Full Text]

				E. Adams and M. Buchfelder Comment on Human Fetal Pituitary Expresses Functional GHRP Receptorsd J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2216 - 2216. [Full Text]

				E. F. Adams, B. Huang, M. Buchfelder, A. Howard, R. G. Smith, S. D. Feighner, L. H. T. van der Ploeg, C. Y. Bowers, and R. Fahlbusch Presence of Growth Hormone Secretagogue Receptor Messenger Ribonucleic Acid in Human Pituitary Tumors and Rat GH3 Cells J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 638 - 642. [Abstract] [Full Text]